相关实验视频

Updated: Jun 17, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

475

将抗组织因子抗体序列转化为嵌合抗原受体和双特异性T细胞参与器格式

S C Saunderson1, J C Halpin1,2, G M Y Tan1,3

  • 1Department of Microbiology and Immunology, University of Otago, Dunedin, 9016, New Zealand.

Cancer immunology, immunotherapy : CII
|August 6, 2024
PubMed
概括

用抗体形式向组织因子 (TF) 为固体癌症治疗提供了一个有希望的策略. 这些抗TF生物药物可以被条件激活,以提高治疗疗效.

关键词:
双特异性T细胞参与者.化学抗原受体的化学抗原受体表面等离子体共振是什么?组织因子 组织因子

更多相关视频

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

53.2K
Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

2.5K

相关概念视频

Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
551